Abbott ramps up Libre 3 production amid shortages
Sep 20, 2024 · MedTech industry news. “Essentially, some patients are seeing delays in their scripts getting filled at certain U.S. retail pharmacies due to a low on-shelf inventory, and while there are likely some minor supply issues causing these script delays, demand also has been very strong as Abbott continues to gain share in the U.S.,” Marcus wrote on Thursday.
Medical Technology News | MedTech Dive
MedTech Dive provides medical technology news and analysis for industry professionals. We cover medical devices, diagnostics, digital health, FDA regulation and compliance, imaging, and more.
What’s next at Masimo after CEO Kiani’s exit? | MedTech Dive
Sep 30, 2024 · Masimo’s leadership transition brings a two-year boardroom feud to a close, but questions remain about the path forward in the wake of CEO Joe Kiani’s exit.
Smith & Nephew laying off about 150 employees in Tennessee
Dec 6, 2024 · Dive Insight: Smith & Nephew, a maker of hip and knee implants and wound care systems, initiated a plan in 2021 aimed at regaining momentum in its underperforming orthopedics unit and improving productivity and efficiency to drive overall growth. The strategy included streamlining the orthopedics portfolio and a review of the manufacturing network.. The …
Abbott and Dexcom are launching the first over-the-counter …
Jun 26, 2024 · The new devices could allow the companies to reach about 25 million people in the U.S. with Type 2 diabetes who don’t take insulin, 15 million people who have been diagnosed with pre-diabetes and an estimated 85 million people who have undiagnosed pre-diabetes, William Blair analyst Margaret Kaczor Andrew said in an interview.
Medtech companies lay off thousands in 2024, continuing last …
Feb 12, 2024 · The latest announcements continue a top industry trend from 2023.A MedTech Dive analysis of state Worker Adjustment and Retraining Notification databases found that medical device companies announced layoffs for more than 14,000 employees between Jan. 1, 2023, and June 30, 2024.. Last year, Medtronic, Abbott, Boston Scientific and Johnson & …
Establishment Labs wins FDA approval for Motiva breast implants
Sep 30, 2024 · Dive Brief: Establishment Labs received Food and Drug Administration approval for its Motiva breast implants for primary and revision breast augmentation.; Motiva is the first new breast implant to receive U.S. premarket approval since 2013, according to Establishment Labs’ Thursday announcement.
FDA finalizes guidance on device shortage reporting rules
6 days ago · Dive Insight: Industry groups pushed back against the first draft in 2022, warning that the scope of the document may cause overreporting. The FDA responded in 2023 by proposing a list of product codes that would be subject to the reporting requirements.
The top medtech trends in 2024 | MedTech Dive
Jan 31, 2024 · Several Wall Street analysts also pointed to pulsed field ablation (PFA) as an emerging market to watch this year. Medtronic announced the first Food and Drug Administration approval for a PFA system in December, and Boston Scientific recently said it got the green light for its system, launching what is expected to be a competitive space for the next several years …
The number of AI medical devices has spiked in the past decade
Oct 9, 2024 · The number of medical devices with artificial intelligence technology has risen sharply in the past decade. The Food and Drug Administration has authorized 950 AI or machine learning-enabled devices as of Aug. 7, 2024, according to the agency’s database. While the FDA authorized the first AI-enabled device in 1995, the number of submissions has spiked in recent …